Researcher Profile

Ban, Hyun Seung image
Ban, Hyun Seung(반현승) 96

Biotherapeutics Translational Research Center (바이오신약중개연구센터)

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 96 (Search time: 0.002 seconds).

No. Year Title Type
96 2025

2025Patent

SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물US17/234,455 (2021.04.19) / 1,2397,011 (2025.08.26)원미선; 김보경반현승박경찬; 염영일
Patent
95 2025

2025Article

Gemcitabine resistance by CITED4 upregulation via the regulation of BIRC2 expression in pancreatic cancerJournal of Biomedical Science, vol. 32, pp. 49-49Eun Jeong Jeong; YuNa Roh; Eunsun Jung; Jin-Seong Hwang; Taesang Son; Hyun Seung BanJang Seong Kim; Y K Choo; Tae-Su Han
Article
94 2025

2025Article

Fusogenic nanoreactor-based detection of extracellular vesicle-derived miRNAs for diagnosing atherosclerosisSmall, vol. 21, no. 23, pp. 2501789-2501789Jiyoon Lee; Kiyoon Kwon; Min Ji Cho; Taesang Son; Yuna Roh; Sugi LeeDae Soo KimMoo-Seung LeeHyun Seung BanJang Seong Kim, et al.
Article
93 2025

2025Article

Prodigiosin regulates cancer metabolism through interaction with GLUT1Natural Product Research, vol. 39, no. 18, pp. 5264-5271Hyun A Yang; Tae Hee Han; Keeok Haam; Kyung-Soo Lee; Jinsu Kim; Tae-Su HanMoo-Seung LeeHyun Seung Ban
Article
92 2025

2025Article

A serum exosomal microRNA?based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinomaCancer Communications, vol. 45, no. 9, pp. 1188-1193Jin-Seong Hwang; Sugi Lee; G Kim; H Jeong; Kiyoon Kwon; Eunsun Jung; Yuna Roh; Taesang Son; Hana LeeMoo-Seung Lee, et al.
Article
91 2025

2025Research Project

막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2025.01.01 ~ 2025.12.31
Research Project
90 2025

2025Research Project

폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2025.03.01 ~ 2026.02.28
Research Project
89 2024

2024Patent

SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물CN201980068374.8 (2021.04.16) / ZL201980068374.8 (2024.08.20)원미선; 김보경반현승박경찬; 염영일
Patent
88 2024

2024Research Project

막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2024.01.01 ~ 2024.12.31
Research Project
87 2024

2024Research Project

재발성 및 불응성 다발성골수종 치료를 위한 19S RP UCHL5 저해 화합물 개발 = Development of 19S RP UCHL5 inhibitors for the treatment of relapsed and refractory multiple myeloma연구책임자 : 반현승 / 사업기간 : 2024.01.01 ~ 2024.07.31
Research Project
86 2024

2024Article

Stilbenoid derivatives as potent inhibitors of HIF-1α-centric cancer metabolism under hypoxiaBiomedicine & Pharmacotherapy, vol. 176, pp. 116838-116838Tae Hee Han; J Lee; D S Harmalkar; H Kang; G Jin; M K Park; M Kim; Hyun A Yang; Jinsu Kim; S J Kwon, et al.
Article
85 2024

2024Research Project

폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2024.03.01 ~ 2025.02.28
Research Project
84 2024

2024Article

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung KangBo Kyung Kim, et al.
Article
83 2024

2024Research Project

특정이자 활용사업(바이오의약연구부) = 특정이자 활용(바이오의약연구부)연구책임자 : 지승욱 / 사업기간 : 2024.03.18 ~ 2024.12.31
Research Project
82 2023

2023Patent

UCH37 탐지용 프로브 및 이의 용도KR10-2021-0142123 (2021.10.22) / 10-2576102-0000 (2023.09.04)반현승; 원미선; 한태수; 한태희
Patent
81 2023

2023Patent

DDIAS 억제제 및 사멸 수용체 리간드를 포함하는 암의 예방 또는 치료용 조성물KR10-2017-0115249 (2017.09.08) / 10-2532779 (2023.05.10)원미선; 임주영김보경반현승
Patent
80 2023

2023Research Project

폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2023.03.01 ~ 2024.02.29
Research Project
79 2023

2023Article

The EDN1/EDNRA/β-arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylationInternational Journal of Oncology, vol. 62, pp. 13-13Yeo Jin Lee; Eunsun Jung; Jinhyeon Choi; Jinseong Hwang; Eun-Jeong Jeong; Yuna Roh; Hyun Seung Ban; Sunhong Kim; Seon-Kyu KimSeon-Young Kim, et al.
Article
78 2023

2023Article

Hemicyanine-based near-infrared fluorescence off-on probes for imaging intracellular and in vivo nitroreductase activityInternational Journal of Molecular Sciences, vol. 24, no. 7, pp. 6074-6074Sun Hyeok Lee; Chul Soon Park; Kyung Kwan Lee; Tae Hee Han; Hyun Seung BanChang-Soo Lee
Article
77 2023

2023Research Project

재발성 및 불응성 다발성골수종 치료를 위한 19S RP UCHL5 저해 화합물 개발 = Development of 19S RP UCHL5 inhibitors for the treatment of relapsed and refractory multiple myeloma연구책임자 : 반현승 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
1 2 3 4 5